Schonfeld Strategic Advisors’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-109,184	Closed	-$1.14M	–	2692
2023 Q1	$1.14M	Sell	109,184 -10,780	-9%	-$112K	0.01%	909
2022 Q4	$1.23M	Buy	119,964 +46,768	+64%	+$473K	0.01%	1044
2022 Q3	$735K	Buy	73,196 +23,196	+46%	+$232K	0.01%	1485
2022 Q2	$498K	Buy	+50,000	New	+$499K	﹤0.01%	1364

Schonfeld Strategic Advisors's LVAC Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 109,184 shares — an estimated $1.14M sold.

Schonfeld Strategic Advisors first reported a position in LVAC in Q2 2022 and held it in 4 quarters. The position peaked at $1.23M in Q4 2022. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Schonfeld Strategic Advisors reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 109,184 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $1.14M.
Schonfeld Strategic Advisors first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Schonfeld Strategic Advisors's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $1.23M in Q4 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.